BIODESIX
Biodesix is a molecular diagnostics company advancing the development of innovative products for personalizing medicine. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring, and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops, and commercializes multivariate protein diagnostics based on their proprietary mass spectrometry-based discovery platform. VeriStrat, a multi... variate serum protein test, is Biodesix’s first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’s CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve the utility of therapeutic agents.
BIODESIX
Industry:
Biotechnology Health Diagnostics Medical
Founded:
2005-01-01
Address:
Broomfield, Colorado, United States
Country:
United States
Website Url:
http://www.biodesix.com
Total Employee:
101+
Status:
Active
Contact:
303-417-0500
Email Addresses:
[email protected]
Total Funding:
299.97 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Global Site Tag
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-28 | Oncimmune | Oncimmune acquired by Biodesix | N/A |
| 2018-07-09 | Integrated Diagnostics | Integrated Diagnostics acquired by Biodesix | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Biodesix
CRG
CRG investment in Debt Financing - Biodesix
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-10 | Biodesix Announces New Commercial Organization and Executive Appointments |
Official Site Inspections
http://www.biodesix.com Semrush global rank: 2.75 M Semrush visits lastest month: 5.9 K
- Host name: 104.26.2.184
- IP address: 104.26.2.184
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
